263 related articles for article (PubMed ID: 14531817)
41. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
42. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
43. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
44. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
45. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study.
Sánchez-Fructuoso AI; Ruiz JC; Torregrosa JV; González E; Gómez E; Gallego RJ; Troya MI; Jimenez C; Llamas F; Romero R; Bernis C; Crespo JF; Guirado L;
Adv Ther; 2012 Nov; 29(11):979-91. PubMed ID: 23160946
[TBL] [Abstract][Full Text] [Related]
46. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Am J Kidney Dis; 2005 Oct; 46(4):628-34. PubMed ID: 16183417
[TBL] [Abstract][Full Text] [Related]
47. Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.
Locatelli F; Olivares J; Walker R; Wilkie M; Jenkins B; Dewey C; Gray SJ;
Kidney Int; 2001 Aug; 60(2):741-7. PubMed ID: 11473657
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of renal anemia with darbepoetin alfa administered once every other week in predialysis patients with chronic kidney disease and previously treated with epoetin alfa].
Molina M; García Hernández MA; Navarro MJ; Pérez Silva F; Cacho M; De Gracia MC
Nefrologia; 2004; 24(1):54-9. PubMed ID: 15083958
[TBL] [Abstract][Full Text] [Related]
49. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
[TBL] [Abstract][Full Text] [Related]
50. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
Patel M; Thimons DG; Winston JL; Langholff W; McGowan T
J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214
[TBL] [Abstract][Full Text] [Related]
51. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
[TBL] [Abstract][Full Text] [Related]
52. Effects of a supplemented hypoproteic diet in chronic kidney disease.
Mircescu G; Gârneaţă L; Stancu SH; Căpuşă C
J Ren Nutr; 2007 May; 17(3):179-88. PubMed ID: 17462550
[TBL] [Abstract][Full Text] [Related]
53. 6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial.
Pisani A; Riccio E; Bellizzi V; Caputo DL; Mozzillo G; Amato M; Andreucci M; Cianciaruso B; Sabbatini M
Clin Exp Nephrol; 2016 Jun; 20(3):433-42. PubMed ID: 26453483
[TBL] [Abstract][Full Text] [Related]
54. Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The "Nutritional Light Signal" of the Renal Acid Load.
Di Iorio BR; Di Micco L; Marzocco S; De Simone E; De Blasio A; Sirico ML; Nardone L;
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106712
[TBL] [Abstract][Full Text] [Related]
55. Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.
Jeffrey RF; Kendall RG; Prabhu P; Norfolk DR; Will EJ; Davison AM
Clin Nephrol; 1995 Oct; 44(4):241-7. PubMed ID: 8575124
[TBL] [Abstract][Full Text] [Related]
56. Reversible uremic deafness: is it correlated with the degree of anemia?
Shaheen FA; Mansuri NA; al-Shaikh AM; Sheikh IA; Huraib SO; al-Khader AA; Zazgornik J
Ann Otol Rhinol Laryngol; 1997 May; 106(5):391-3. PubMed ID: 9153103
[TBL] [Abstract][Full Text] [Related]
57. Low protein diet in uremia: effects on glucose metabolism and energy production rate.
Rigalleau V; Combe C; Blanchetier V; Aubertin J; Aparicio M; Gin H
Kidney Int; 1997 Apr; 51(4):1222-7. PubMed ID: 9083290
[TBL] [Abstract][Full Text] [Related]
58. Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure.
Prakash S; Pande DP; Sharma S; Sharma D; Bal CS; Kulkarni H
J Ren Nutr; 2004 Apr; 14(2):89-96. PubMed ID: 15060873
[TBL] [Abstract][Full Text] [Related]
59. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients.
Clyne N; Jogestrand T
Nephron; 1992; 60(4):390-6. PubMed ID: 1584314
[TBL] [Abstract][Full Text] [Related]
60. The precision of estimating protein intake of patients with chronic renal failure.
Masud T; Manatunga A; Cotsonis G; Mitch WE
Kidney Int; 2002 Nov; 62(5):1750-6. PubMed ID: 12371976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
